Orthofix International Sales Offset U.S. COVID Declines
The company grew in the low single-digits for 3Q21 as its spine and international businesses offset COVID declines in the U.S. Nov 08, 2021
We've found 292 results
Zimmer Biomet Prepares for Longer Downturn
The company's 3Q21 orthopedic sales declined -0.5% due to procedure delays, staffing shortages and larger-than-expected impact from China. Nov 05, 2021
SeaSpine Increases Investments to Fuel Growth
SeaSpine grew in the high single digits for 3Q21 and continues its investments to drive share gains and growth. Nov 04, 2021
ConMed Maintains Cautious Outlook on Pandemic Recovery
The company grew in the low single digits for 3Q21 and anticipates a gradual recovery from declines brought on by the Delta variant. Nov 02, 2021
Stryker’s Organic Growth Impacted by Autumn Surges
The company's orthopedic business grew only 2% organically in 3Q21 due to the Delta variant and hospital staffing shortages. Nov 01, 2021
DePuy Synthes Expects Healthy Volume Recovery to End 2021
The company grew 0.5% in the third quarter of 2021 compared to the year prior as procedure declines peaked in July and August. Oct 20, 2021
IPO Landscape Favorable for Orthopedic Players
Three companies – Treace Medical Concepts, Bioventus and Paragon 28 – made the leap in 2021. Market conditions could induce more to go public in 2022. Oct 20, 2021
Episurf Developing MTP Joint Implant
The company targets the filing of an FDA 510(k) application for the Episealer MTP system late 2022 or first half of 2023. Sep 28, 2021
Royal Biologics Takes Diverse Approach to Autologous Live Cell Therapy
While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC portfolio. Sep 22, 2021
Orthopedic Market Nears Normalization as 2021 Winds Down
The orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant. Sep 08, 2021
